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cyclic strain) and a resultant elevated shear. Shear is affected
by flow rates, and cyclic strain is related to compliance of
the graft. Thus, the flow through the graft and the ability
of the graft to stretch and recoil during pulsatile flow can
affect the production of molecules by endothelial cells.
Clinically, inadequate flow is associated with graft failure,
and experimentally, low flow correlates with decreased pro-
duction of NO and increased intimal hyperplasia in vein
grafts.7-9 Previous work in our laboratory has associated
decreased graft compliance with poor patency.10,11
One critical component of graft patency, endothelial
resistance to thrombus formation, is intimately related to
the hemodynamic conditions of the bypass including flow,
pulsatility, and compliance. In response to long-term
exposure to arterial hemodynamics, vein grafts undergo an
adaptation termed arterialization, making the physical
characteristics resemble those of native arteries.8 Evidence
of this adaptation, combined with the noted superior per-
formance of arterial conduits in coronary bypass12 could
indicate that this adaptation is important to patency.
NO is known to play a critical role in vascular physiol-
ogy and pathophysiology. NO production has been
demonstrated to abrogate intimal hyperplasia and throm-
bosis.13-15 Little is known about the role of NO in bypass
grafts.
To date, the development of an ideal biological or syn-
thetic bypass conduit has eluded researchers. The theoret-
ically consummate bypass conduit would consist of a
normally functioning endothelial cell surface and mechan-
ical properties that approach those of native arteries.1
The endothelium helps maintain graft patency by pro-
ducing various vasoactive and thrombolytic molecules.2,3
Forces such as fluid shear and cyclic strain acting on the
endothelium can influence production of these factors 
such as nitric oxide (NO), which are favorable to graft
patency.2-6 On implantation into the arterial circulation, a
vein graft is subjected to dramatic changes in hemody-
namic forces, being transplanted from a nonpulsatile, low-
pressure, low-flow environment with minimal shear stress
to a high-pressure system with pulsatile flow (leading to
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Introduction: Evidence exists that an ideal bypass conduit should have a functional endothelial cell surface combined
with mechanical properties similar to those of native arteries. We hypothesized that the effect of combined arterial lev-
els of pulsatile shear stress, flow, and cyclic strain would enhance saphenous venous endothelial cell nitric oxide (NO)
production, and that variations in these “ideal” conditions could impair this function. We studied NO production as a
measure of endothelial function in response to different hemodynamic conditions.
Methods: Human adult saphenous venous endothelial cells were cultured in 10-cm silicone tubes, similar in diameter (5
mm) and compliance (6%) to a medium-caliber peripheral artery (eg, popliteal). Tube cultures were exposed to arterial
conditions: a combined pressure (120/80 mm/Hg; mean, 100 mm/Hg), flow (mean, 115 mL/min) and cyclic strain
(2%), with a resultant pulsatile shear stress of 4.8 to 9.4 dyne/cm2 (mean, 7.1). Identical tube cultures were used to
study variations in these conditions. Modifications of the system included a noncompliant system, a model with non-
pulsatile flow, and a final group exposed to pulsatile pressure with no flow. NO levels were measured with a fluoro-
metric nitrite assay of conditioned media collected at 0, 0.25, 0.5, 1, 2, and 4 hours. Experimental groups were
compared with cells exposed to nonpulsatile, nonpressurized low flow (shear stress 0.1 dyne/cm2) and static cultures.
Results: All experimental groups had greater rates of NO production than cells under static conditions (P < .05). Cells
exposed to ideal conditions produced the greatest levels of NO. Independent decreases in compliance, flow, and pul-
satility resulted in significantly lower rates of NO production than those in the group with these conditions intact (vs
noncompliant P < .05, vs nonflow P < .05, and vs nonpulsatile P < .05).
Conclusions: Our results show that in the absence of physiologically normal pulsatility, cyclic strain, and volume flow,
endothelial NO production does not reach the levels seen under ideal conditions. Pulsatile flow and compliance (pro-
ducing flow with cyclic stretch) play a key role in NO production by vascular endothelium in a three-dimensional hemo-
dynamically active model. This correlates biologically with clinical experience linking graft inflow and runoff and the
mechanical properties of the conduit to long-term patency. (J Vasc Surg 2001;33:1199-205.)
We hypothesized (1) that the combined effect of arte-
rial levels of pulsatile shear stress, flow, and cyclic strain (a
result of a compliant graft) could promote endothelial
resistance to thrombus formation and intimal hyperplasia
by promoting NO production and (2) that changes in
these “ideal” conditions, such as decreased compliance or
pulsatile flow, could limit this function of the endothe-
lium. To test our hypothesis we used a three-dimensional
biomimetic device previously developed in our laboratory
that mimics the combined hemodynamic conditions expe-
rienced in a peripheral vein graft and applies them to an
endothelial monolayer similar to the intima of a vein.16
METHODS
Establishment of endothelial cell cultures
Adult human venous endothelial cells (HVEC) were
isolated from discarded saphenous vein segments obtained
from patients undergoing cardiac or peripheral vascular
bypass surgery at the Massachusetts General Hospital.
Tissues were obtained under strict National Institutes of
Health guidelines regulated by the Massachusetts General
Hospital Subcommittee on Human Studies.
Vein segments were cannulated with no. 19 Marks
needles, flushed with chilled balanced salt solution
(GIBCO, Rockville, Md), and filled with 0.1% collagenase
(CLS II; Worthington, Frechold, NJ) warmed to 37°C,
containing 0.5% bovine serum albumin (Fraction V; Sigma
Chemical Co, St Louis, Mo) and 0.1% soybean trypsin
inhibitor (Sigma) in Medium 199 (M199) (GIBCO) with
Hank’s balanced salt solution (GIBCO). The segments
were then incubated in a bath of balanced salt solution for
20 to 30 minutes at 37°C. Endothelial cells were removed
by flushing each vein segment with M199. The enzymatic
dissociation was stopped by addition of complete, serum-
containing medium, and subsequently the cells were col-
lected by centrifuging the effluent for 5 minutes at 500g.
Cells were cultured in M199 with 25 mmol/L HEPES, to
which 0.18% sodium bicarbonate, 20% fetal bovine serum
(Hyclone Laboratories Inc, Logan, Utah), 150 µg/mL
heparin (Sigma), 2 mmol/L L-glutamine (GIBCO), 50
µg/mL endothelial cell growth supplement (Bectin
Dickenson, Franklin Lakes, NJ), and penicillin/strepto-
mycin (100 U/mL and 100 mg/mL, respectively,
GIBCO) were added. The cells were fed three times per
week and incubated in an atmosphere of 95% air and 5%
CO2 at 37°C. The cells were passaged with trypsin-EDTA
(0.05%, 0.53 mmol/L, respectively, GIBCO). They were
plated on 1% gelatin-coated culture flasks. Cell cultures
(passages 3-5) were documented to maintain their stan-
dard morphologic appearance. 
Cells were seeded at confluent densities (105 cells per
square centimeter) onto 0.01% fibronectin-coated silicone
rubber tubes (Becton Dickinson). After 12 hours’ incubation
at 37°C under rotation to establish tube cultures, experi-
mental cultures were exposed to combinations of pressurized
pulsatility, flow, and cyclic strain (Table I), and NO levels in
conditioned media were assayed (see later). After exposure to
experimental conditions, cells were harvested from the tubes
with trypsin-EDTA (GIBCO), washed in Dulbecco phos-
phate-buffered saline, and counted.
Experimental systems
Vascular simulating device. The biomimetic device
consists of silicone rubber tubes attached to a flow system
enclosed in a 37°C humidified incubator, with 5% CO2.
A description of the vascular simulating device (VSD) and
analysis of the device have been published previously.16
Dimethyl silicone elastomer tubes were custom manufac-
tured with previously determined specifications (Specialty
Manufacturing Inc, Saginaw, Mich).16 The tubes measure
10 cm in length and have a similar diameter (5 mm) and
compliance (6%) to a medium-caliber artery. All experi-
ments were run with the same culture media consisting 
of M199 with 25 mmol/L HEPES, to which 0.18%
sodium bicarbonate, 20% fetal bovine serum, 2 mmol/L
L-glutamine, and penicillin/streptomycin were added.
Dextran (Sigma) was added to the media to a concentra-
tion of 4% to increase the viscosity to that of blood. The
tube cultures were exposed to four experimental sets 
of conditions with the previously described VSD and
three modifications of the system. To simulate ideal graft
conditions, we used the VSD to expose the cells to com-
bined pulsatile “arterial” conditions: pressure 120/80
mm/Hg (mean, 100 mm/Hg); flow mean, 115 mL/min;
cyclic strain 2%; and a resultant pulsatile shear stress of 4.8
to 9.4 dyne/cm2 (mean, 7.1) (Fig 1). Experimental tube
cultures were compared with identical tube cultures
exposed to nonpulsatile, nonpressurized low flow similar
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Fig 1. VSD. Media are in the reservoirs (1, 2), and rubber tubes’
total volume is 90 mL. Bellows pump (labeled pump) cycles at
60/min and provides pulsatile pressure that is augmented by gas
through the tubing (4). Combined force enters dampening reser-
voir (1), which eliminates bubbles and regulates pulse pressure. Box
with culture tubes (6). Arrows indicate direction of flow. Media fill-
ing port (3). Pressure stopcock (5). Connecting stopcock (7).
to those of the venous circulation (shear stress, 0.1
dyne/cm2), and HVECS grown on fibronectin-coated flat
culture dishes.
Modifications of the VSD. All modifications of the
VSD were analyzed for hemodynamic parameters running
with viscous media identical to that used for the experi-
ments. Tubes in each system were visualized under
microscopy and analyzed for changes in diameter over
time (compliance) with video motion analysis equipment
and software (Video Motion Analyzer Model VP 110;
Video Motion Analysis, Santa Rosa, Calif) as previously
described. Pressure was monitored with a pressure trans-
ducer connected to a Gould Chart Recorder (Model
2200S; Gould, Cleveland, Ohio). Flow was recorded with
an ultrasound probe (Model T109; Transsonic Systems
Inc, Ithaca, NY). We added 100 µL of a 10% latex bead
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solution (SD 26, 23.5 µ diameter, Sigma) to 90 mL of
media in each modified system, and flow was observed
under microscopy to visualize any flow disturbances com-
pared with the original simulating device.
Noncompliant modification. A noncompliant system
used rigid plastic external stents 5 mm in diameter to sur-
round the tube cultures. The stents rendered the tubes
noncompliant resulting in the following conditions: pul-
satile pressure 120/80 mm/Hg (mean, 100 mm/Hg);
flow mean, 115 mL/min; no cyclic strain; shear stress 4.8
to 9.4 dyne/cm2 (mean, 7.1) (Table I).
Nonpulsatile modification. For the nonpulsatile system
the bellows pump was replaced with a high-flow roller
pump (MasterFlex Quickload Model No. 7550-60; Cole-
Parmer Co, Chicago, Ill) and three damper reservoirs to
minimize pulsatility (Table I). The resulting conditions
Table I. Hemodynamic conditions for the experiments, including the VSD and modifications
Experimental Pressure Flow Shear stress
system (mm/Hg) (mL/min) Pulsatility Compliance Cyclic stretch (dyne/cm2)
VSD ideal 120/80 115 Yes 6% 2% 4.8-9.4 (mean, 7.1)
Noncompliant 120/80 115 Yes 0% 0% 4.8-9.4 (mean, 7.1)
Nonpulsatile 100 115 No 6% 0% 7.1
No flow 120/80 0 Yes 6% 2% 0
Low flow 1.5 No 0% 0% 0.1
Static 0 No 0% 0% 0
Fig 2. Cumulative nitrite production (mean ± SEM), all conditions. Asterisks indicate significant differences from static cultures (P ≤
.05). VSD, Vascular simulating device.
were nonpulsatile pressure 100 mm/Hg; nonpulsatile
flow 115 mL/min; no cyclic strain; and a nonpulsatile
shear stress of 7.1 dyne/cm2 (Table I).
No-flow modification. The VSD was modified by occlud-
ing flow through the distal end of the tube to generate
pulsatility with no flow (Table I). The no-flow conditions
were pulsatile pressure 120/80 mm/Hg (mean, 100
mm/Hg); no flow; cyclic strain 2%; and no shear stress.
Nitrite assay
NO production by cultured HVECs was assayed by
measuring nitrite, an oxidation product of NO. Nitrite has
been shown to reflect more than 75% of NO produced by
vascular cells in culture.17 Conditioned media were col-
lected at 0, 0.25, 0.5, 1, 2, and 4 hours from experimen-
tal and control groups, and nitrite levels were measured
with a fluorometric assay.18 Nitrite in the conditioned
media reacts with an acid form of DAN (2,3-diaminon-
apthalene) (non-fluorescent) to form the fluorescent
product 1-H-naphthotriazole. We added 800 µL of freshly
prepared DAN (0.05 mg/mL in 0.62 N HCL) to 3 mL
of sample media, and the mixture was incubated at 20°C
in the dark for 10 minutes. We added 200 µL of 2.8 N
NaOH to maximize the intensity of the fluorescent end
product. The signal was measured with an excitation fluo-
rometer with excitation at 380 nm and emission at 460
nm. Nitrite concentrations were determined relative to a
standard curve. Nitrite production numbers were normal-
ized to cell number for each experiment.
Statistical analysis
Data are expressed as mean ± SE. Comparisons were
made with one-way analysis of variance and paired t test.
A P value less than .05 was considered statistically signifi-
cantly different.
RESULTS
Cells exposed to the combination of pulsatile flow and
a compliant conduit (ideal conditions) had a dramatic
increase in nitrite production within the first 15 minutes
(264.9 ± 113.1 nm per million cells). The rate of produc-
tion was greatest within the first 15 minutes (1059.6 ±
469.6 nm/mL per hour).There was a 30-fold greater pro-
duction compared with static controls (Fig 2, P < .05).
There was 90% of nitrite production occurring within the
first 15 minutes, and 95% by 30 minutes. Nitrite produc-
tion continued as a gradual release up to 4 hours. Cells
exposed to pulsatile flow with a noncompliant tube had a
greater level of nitrite production (76.1 ± 37.99 nm per
million cells, Fig 2) than the static cultures, although this
was not significant. Conditions in the noncompliant system
resulted in a rate of nitrite production one third that of cells
in the compliant system (P < .05, Fig 3).
Nonpulsatile flow resulted in a similar pattern to the
noncompliant system with a ninefold lower production
rate compared with the cells exposed to ideal conditions
(P < .05). The total nitrite production was not signifi-
cantly greater than the static cultures (Table II). 
The cells exposed to pulsatility with no flow did not
differ significantly from static cultures. The rate of pro-
duction was significantly lower than that of the cells under
combined arterial conditions (P < .05, Fig 3).
The combination of pulsatility, flow, and a compliant
tube resulted in the greatest nitrite production by
endothelial cells and was the only group with total levels
significantly greater than the static controls. Independent
decreases in compliance and pulsatility showed signifi-
cantly lower rates of nitrite production (Table II).
DISCUSSION
Adequate inflow and runoff for arterial bypass has
been well established as being critical to maintaining graft
patency.1,19 The effects of mechanical properties of the
graft have also been shown to play a significant role in the
success or failure of a bypass graft.1,10,11,19 Experiments
with endothelial cells in flat culture have shown that shear
stress (related to volume flow) and cyclic strain can affect
cell function, leading to the production of molecules such
as NO conferring resistance to thrombus formation and
intimal hyperplasia.20-23 Our three-dimensional model has
been used previously to study endothelial cells in an envi-
ronment more closely resembling that of a peripheral
bypass graft.16,24,25 The system is well suited to bridge the
gap between in vitro cell culture studies and in vivo stud-
ies and has enabled us to study the effects of combined
forces on an endothelial monolayer.
NO is a short-lived humoral substance that has been
studied extensively in the literature over the past 10 years.
Certain physiologic and pathologic triggers have been
demonstrated to induce release of NO. For instance, the
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Table II. Nitrite production rates and total nitrite production for the VSD and modifications of the system 
Experimental Maximum rate of nitrite production Total nitrite production
system (nm/million cells/h) (nm/million cells)
VSD ideal 1058.96 ± 469.6 266.4 ± 113.1
Noncompliant 297.2 ± 107.8 76.14 ± 37.99
Nonpulsatile 136.65 ± 58.1 77.73 ± 13.1
No flow 147.9 ± 65.5 104.6 ± 12.64
Low flow 180.46 ± 94.9 59.33 ± 15.74
Static 29.86 ± 1.73
stimulation of the cell by endothelial stretch, by hypoxia,
and by platelet products such as thrombin, adenosine
triphosphate, and serotonin stimulate vascular endothe-
lium to release NO.26 In this study, we have demonstrated
that both cyclic stretch (a result of a compliant tube and
pulsatile flow) and shear stress (dependent on flow) are
required for the production of endothelial NO. There is
an initial rise in NO production with sustained elevation
compared with controls. The likely explanation for the
continued elevation of NO is due to the protracted hemo-
dynamic conditions and not secondarily to a burst effect.
This has been demonstrated previously when endothelial
cells are exposed to high shear forces.27 Furthermore, our
study demonstrated that independent changes in these
parameters resulted in decreased NO production as evi-
denced by decreased nitrite in the media. Volume flow
alone did not elicit the same response as flow combined
with cyclic stretch of the cell layer. Previous work has
demonstrated that on initial implantation into the arterial
circulation, vein grafts distend and have a reduced compli-
ance at arterial levels of pressure.28 The result is flow with
minimal cyclic stretch compared with native arteries. Over
time, the vein adapts to its new environment by remodel-
ing the medial layer with a better ability to accommodate
arterial flow.19,28 The “arterialized” vein now has the abil-
ity to stretch and recoil with the pulsatile pressure and
flow of the arterial system. The superior long-term
patency of arterial conduits as seen with coronary artery
bypass might be related, in part, to the mechanical prop-
erties of the graft and the ability to accommodate arterial
hemodynamics.12 Interestingly, the inducible form of NO
synthase has been shown to be upregulated in aortocoro-
nary vein grafts compared with infrainguinal grafts in
human beings.29 Our results demonstrate that the condi-
tions generated by a more compliant conduit may alter
endothelial cell function when compared with a noncom-
pliant conduit. The current literature suggests NO may be
beneficial in maintaining graft patency by diminishing inti-
mal hyperplasia through a variety of mechanisms.19,23 The
diminished level of NO produced by the endothelial cells
in our model under individual hemodynamic conditions
could help explain why grafts fail when hemodynamics are
altered in these grafts. Thus, NO production by endothe-
lial cells may provide an initial protective mechanism
against early graft failure.
The pathogenesis of vein graft failure is complex.
Forces such as para-anastomotic flow disturbances and
compliance mismatch are important determinants in graft
patency.8,10 The process of denudation of the endothe-
lium when veins are sewn into the arterial circulation and
subsequent exposure of the highly thrombogenic suben-
dothelium has likewise been implicated in this process.
Our experiments focused on the hemodynamics that
would be encountered in the midportion of the conduit.
The model did not have flow disturbances as seen at the
para-anastomotic region of a graft. Our goal was to study
the effect of compliance, flow, and pulsatility on endothe-
lial cells without the other confounding variables. We
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think this is the only way to look mechanistically at how
the endothelium reacts to altered hemodynamics. There
are several questions which arise from our initial work: (1)
Is there a threshold effect, or levels of shear stress and
cyclic strain at which the synergistic effect on the endothe-
lial cells is optimized? (2) What effects do these forces have
at the transcription and translation levels? (3) How does
cell-to-cell interactions affect this process (eg, smooth
muscle cell and endothelial cell coculture)? (4) Can a vein
graft be prepared to accommodate arterial pressures (eg, a
compliant external support/stent) to allow for improved
endothelial function and to protect the vein in its new
environment? These questions can be studied with our
flow system and possibly with in vivo experiments.
In conclusion, our work shows that there is a syner-
gistic effect of pulsatile flow and cyclic strain on the pro-
duction of NO in a three-dimensional hemodynamically
active model. Independent changes in compliance, flow,
and pulsatility lead to differences in NO production,
which could partially explain differences in graft patencies
with various conduits, each of which has unique hemody-
namic environments. 
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DISCUSSION
Dr Bauer Sumpio (New Haven, Conn). That indeed was a
very nice presentation. However, I am a bit confused, and I take
issue with your conclusions. The conclusion you made was that
the lack of hemodynamic factors made it so that nitric oxide pro-
duction did not achieve “ideal.” In fact, if you try to measure
nitrite in the arterial system in physiologic situations under both
venous and arterial conditions, there is very little in the circula-
tion, even in the microenvironment, perhaps less than 10
µmol/L. The question of whether or not what you have seen, in
terms of hundreds of micromolar production of nitrite in your
model, is indeed ideal or not I think is up to question. With that
sort of preamble I also noted as you have that in all groups the
increase in nitrite occurred in the first half hour. After that the
production was the same. So in fact after this initial stress on 
the grafts there was no difference in the production of nitrite and
hence nitric oxide in any of the groups. It raises the issue of
whether or not there is any hierarchy or synergistic effect among
those three different forces. The last question is, what is the
mechanism by which this nitrite increases in the first half hour? It
cannot be an increase in nitric oxide synthase, in other words
mRNA transcription, because we know that takes about 2 to 4
hours. So it has to be just an increase in synthesis, either by an
increase in uptake of arginine or any of the cofactors. What do
you think the mechanism might be of that initial spurt? Would
conditioning experiments be more relevant, in other words, keep-
ing them at a certain level and then changing the various param-
eters?
Dr Patrick J. Casey. Thank you, Dr Sumpio. To address your
first question about that, this may not be biologically relevant. I
agree there is a burst of nitric oxide release within the first 15
minutes, and this may not have any true significance to actual
function. I think that the reason why it may level off is possible
inhibition by the presence of nitric oxide or the presence of nitrite
in the media, which could affect further production by the cells
and longer-term experiments will have to look at that. We are
planning on looking at the levels of nitric oxide synthase—we
started to do that already—and then look at the levels of eNOS
and iNOS and then also introduce some inhibitors as well to elu-
cidate the mechanism in this system.
The final question was?
Dr Sumpio. Is there really a difference in the rate of produc-
tion after that initial burst between those two models?
Dr Casey. After the initial burst, no. The initial rate to achieve
an initial level, there is a difference, but after that, no. They all
level off after about half an hour.
Dr Sumpio. Thank you.
Dr Casey. Thanks.
Dr Allan Callow (Chestnut Hill, Mass). I think this is a great
paper, and my worthy colleague from the south whose advice I
usually follow when it comes to endothelial cells notwithstanding,
this is an excellent presentation. Bauer, I think you have to agree
that nitric oxide is a good molecule most of the time and that if
it is present from the very onset of restoration of blood flow it is
probably even better.
Two technical questions: At what passage were these cells?
You extracted or removed them from segments of residual veins.
How long were cells kept in culture? Because as the number of
passages increase, the ability of the endothelial cells to produce
the beneficial molecules decreases.
The second question: in most flow experiments, an immedi-
ate loss of cells occurs and what one measures is what is produced
by the cells remaining. Fibronectin coating does result in better
retention. There is a substantial immediate loss that occurs within
the first 10 or 15 minutes of restoration of flow that might
explain why you saw a leveling off of the production, simply
because there are fewer cells.
From a practical point of view, do you think it will be possi-
ble to provide endothelial cells with those elements to which they
are accustomed, namely, smooth muscle cells and extracellular
matrix? For a practical application, how does one really create the
optimal environment? You have really simulated or duplicated the
conditions of flow for which I congratulate you, but there is
another problem in reproducing the biologic conditions.
All in all I thought it was a splendid paper. Thank you.
Dr Casey. Thank you, Dr Callow. For the first question, the
passage of cells was between passage 4 and passage 6 for these
experiments.
As far as the adherence of the cells following the flow experi-
ments, I did not mention that following each experiment the tubes
were inspected in a similar fashion to preexperiment to visualize the
endothelial monolayer and as well, cells are counted, but we
inspected the tubes following each experiment to ensure that there
continues to be a confluent endothelial monolayer lining the tubes.
We tried to culture smooth muscle cells as well with some
success in these tubes, and the ultimate hope would be to culture
smooth muscle cells and then seed endothelial cells onto them
and finally to do whole vein experiments. So we hope to separate
out each cell layer in the future.
Dr Frank Pomposelli (Boston, Mass). Dr Casey, I am trying
to reconcile this interesting physiologic effect with what we know
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clinically. You said that compliance and shear are important, but
in fact clinically, I think that is probably not true when you are
talking about good-quality autologous vein conduit. Correct me
if I am wrong, but vein conduit in general is a fairly noncompli-
ant structure, and are the mechanical properties in your model
similar to a vein graft?
Second, it has been shown, I think, in modern series of lower
extremity reconstructions that good-quality vein behaves
extremely well in a wide variety of inflow and outflow situations.
For example, a femoropopliteal graft that has high shear rates,
high flows, really behaves no better than a femoropedal or a
femoroperoneal graft with much lower flow rates and presumably
lower shears. So how do you reconcile this physiologic effect, and
is it relevant to what we know clinically about vein grafts?
Dr Casey. Thank you, Dr Pomposelli. To address the first
question, I think that the ideal conduit for bypass would be a
native artery, but in a peripheral bypass situation that is not prac-
tical, but in coronary bypass it appears to be a superior conduit.
We are modeling ideal arterial bypass; this does not mimic a vein
graft. It mimics a compliant conduit. I agree above 50 mm Hg a
vein graft is noncompliant. We were looking at the endothelial
function, and possibly in the future to prepare vein grafts for
bypass it may be reasonable to try and give an external compliant
support. That was part of the thinking, to allow for a more com-
pliant conduit, but as you said, in the real world this effect may
not be as significant as it is experimentally I suppose.
Dr Jens Eldrup-Jorgensen (Portland, Me). I enjoyed this
presentation and thought it was a very cleverly designed study. I
believe you mentioned that nitric oxide levels were normalized
for cell numbers. Although cell function is very important, so is
cell survival. Did you have any quantification of the cell survival
under these different conditions?
Dr Casey. We inspected the cells for adherence, but as far as cell
counting initially a few of the experiments we used trypan blue to
look for cell survival but for all of the experiments we did not use
that so we are not sure about the total cell number survival. We
would wash the tubes and rinse the tubes so that the cells that
would ultimately be counted would be the cells that were adher-
ent over the time course of the experiments so the hope was that
these cells had survived throughout the experiment.
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